10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0000950170-21-001079`
Period End Date	20210630
Filing Date	20210809
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	alhc-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 64 Cash Flow Statement 80 Stockholders Equity 39

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$46.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash	`Cash`	$494.62M	USD	Point-in-time
Cash	`Cash`	$207.31M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of [$46] at June 30, 2021 and $0 at December 31, 2020, respectively)	`AccountsReceivableNetCurrent`	$40.14M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of [$46] at June 30, 2021 and $0 at December 31, 2020, respectively)	`AccountsReceivableNetCurrent`	$66.47M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$31.80M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$17.23M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$264.68M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$592.89M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.14M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	164.06M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$29.53M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.89M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$8.88M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.27M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	164.06M	shares	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$34.65M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$35.31M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	164.06M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.27M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.15M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.45M	USD	Point-in-time
Total assets	`Assets`	$670.06M	USD	Point-in-time
Total assets	`Assets`	$338.50M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$112.61M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$136.48M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$14.62M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$15.68M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$22.64M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$25.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$153.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$173.74M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$144.17M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$147.33M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.61M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$10.27M	USD	Point-in-time
Total liabilities	`Liabilities`	$329.68M	USD	Point-in-time
Total liabilities	`Liabilities`	$307.89M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of June 30, 2021 and December 31, 2020 respectively; no shares issued and outstanding as of June 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of June 30, 2021 and December 31, 2020 respectively; no shares issued and outstanding as of June 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 and 164,063,787 shares authorized as of June 30, 2021 and December 31, 2020 respectively; 187,273,782 and 164,063,787 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$188.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 and 164,063,787 shares authorized as of June 30, 2021 and December 31, 2020 respectively; 187,273,782 and 164,063,787 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$164.00K	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$821.38M	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$410.02M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-379.57M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-481.21M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$340.37M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$30.61M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$42.33M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$354.25M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$50.86M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$78.71M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$338.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$670.06M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$308.74M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$243.96M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$468.22M	USD	2 Qtrs
Earned premiums	`PremiumsEarnedNet`	$575.74M	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$357.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$724.00K	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$294.00K	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$212.00K	USD	1 Quarter
Total revenues	`Revenues`	$468.95M	USD	2 Qtrs
Total revenues	`Revenues`	$244.31M	USD	1 Quarter
Total revenues	`Revenues`	$308.95M	USD	1 Quarter
Total revenues	`Revenues`	$576.03M	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$387.90M	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$525.48M	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$274.38M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$194.50M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$66.48M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$71.15M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$33.70M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$136.06M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.91M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.09M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.64M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.53M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$461.47M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$349.44M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$669.19M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$231.73M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-93.16M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$12.59M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$7.47M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-40.49M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.33M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.58M	USD	2 Qtrs
Interest expense	`InterestExpense`	$4.19M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.35M	USD	2 Qtrs
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-97.00K	USD	2 Qtrs
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$827.00K	USD	2 Qtrs
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-59.00K	USD	1 Quarter
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$30.00K	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-9.18M	USD	2 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.22M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.27M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-8.48M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-44.76M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-101.64M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$8.37M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.71M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$8.37M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-101.64M	USD	2 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-1.71M	USD	2 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-44.76M	USD	1 Quarter
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	176.84M	shares	1 Quarter
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	153.19M	shares	1 Quarter
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	165.70M	shares	2 Qtrs
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	146.97M	shares	2 Qtrs
Net income (loss) per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.05	USD	1 Quarter
Net income (loss) per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	2 Qtrs
Net income (loss) per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.61	USD	2 Qtrs
Net income (loss) per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.25	USD	1 Quarter

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.71M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-101.64M	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$25.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$46.00K	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$38.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$35.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$7.28M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$7.75M	USD	2 Qtrs
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$1.11M	USD	2 Qtrs
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$1.08M	USD	2 Qtrs
Payment-in-kind interest	`PaidInKindInterest`	$2.05M	USD	2 Qtrs
Payment-in-kind interest	`PaidInKindInterest`	$1.97M	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-990.00K	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$51.27M	USD	2 Qtrs
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$676.00K	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$1.31M	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$1.15M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$18.67M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$25.50M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$6.73M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$14.39M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-35.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-6.00K	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$23.11M	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$-1.11M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$6.41M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-2.37M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-2.53M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$1.05M	USD	2 Qtrs
Lease liabilities	`OperatingLeasePayments`	$1.79M	USD	2 Qtrs
Lease liabilities	`OperatingLeasePayments`	$3.14M	USD	2 Qtrs
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	-	USD	2 Qtrs
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	$-3.94M	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.33M	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-61.56M	USD	2 Qtrs
Asset acquisition, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	$1.41M	USD	2 Qtrs
Asset acquisition, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	-	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$1.00M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$800.00K	USD	2 Qtrs
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$800.00K	USD	2 Qtrs
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$250.00K	USD	2 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-6.72M	USD	2 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-9.46M	USD	2 Qtrs
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$100.00K	USD	2 Qtrs
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.38M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.87M	USD	2 Qtrs
Purchase of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	2 Qtrs
Purchase of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$15.00K	USD	2 Qtrs
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.47M	USD	2 Qtrs
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.02M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$135.00M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$390.60M	USD	2 Qtrs
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$29.01M	USD	2 Qtrs
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$3.37M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$360.13M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$130.61M	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$287.71M	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$114.90M	USD	2 Qtrs
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$495.52M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.38M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$495.52M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.38M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$5.41M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.29M	USD	2 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$258.00K	USD	2 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$418.00K	USD	2 Qtrs
Cash	`CashAndCashEquivalentsAtCarryingValue`	$200.88M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$494.62M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$900.00K	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$495.52M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.38M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Common stock issuance costs	`StockIssuedDuringPeriodIssuanceCosts`	$-12.00K	USD	1 Quarter
Common stock issuance costs	`StockIssuedDuringPeriodIssuanceCosts`	$329.00K	USD	1 Quarter
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$42.33M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$354.25M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$50.86M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$78.71M	USD	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.27M	shares	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	164.06M	shares	Point-in-time
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$8.37M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-101.64M	USD	2 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-1.71M	USD	2 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-44.76M	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	2 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	1 Quarter
Common stock issuance costs	`StockIssuedDuringPeriodIssuanceCosts`	$-12.00K	USD	1 Quarter
Common stock issuance costs	`StockIssuedDuringPeriodIssuanceCosts`	$329.00K	USD	1 Quarter
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$361.59M	USD	2 Qtrs
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$131.63M	USD	2 Qtrs
Issuance of common stock to third-party business partners	`StockIssuedDuringPeriodValueToTheThirdPartyBusinessProviders`	$6.48M	USD	2 Qtrs
Issuance of common stock to stock appreication rights holders	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$11.51M	USD	2 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$350.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$33.28M	USD	2 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$30.89M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$676.00K	USD	2 Qtrs
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.02M	USD	2 Qtrs
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.47M	USD	2 Qtrs
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$507.00K	USD	1 Quarter
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$42.33M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$354.25M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$50.86M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$78.71M	USD	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.27M	shares	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	164.06M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.